Agendia to Showcase MammaPrint and BluePrint Utility in Guiding Anthracycline Therapy at the 2025 San Antonio Breast Cancer Symposium

Four additional poster presentations from the ongoing real-world FLEX Read More

2025-11-24T16:36:40-05:00November 25th, 2025|Press Releases|

Agendia to Reveal Novel Breast Cancer Outcome Data Identifying Genomic Risk and Treatment Disparities Among Diverse Patient Population at 2025 ASCO Annual Meeting

FLEX Study Highlights Clinical Utility of MammaPrint® and BluePrint® Read More

2025-06-18T14:05:14-04:00May 27th, 2025|Press Releases|
Go to Top